Abstract:Diet and the gut microbiota have a profound influence on physiology and health, however, mechanisms are still emerging. Here we outline several pathways that gut microbiota products, particularly short-chain fatty acids (SCFAs), use to maintain gut and immune homeostasis. Dietary fibre is fermented by the gut microbiota in the colon, and large quantities of SCFAs such as acetate, propionate, and butyrate are produced. Dietary fibre and SCFAs enhance epithelial integrity and thereby limit systemic endotoxemia. Moreover, SCFAs inhibit histone deacetylases (HDAC), and thereby affect gene transcription. SCFAs also bind to 'metabolite-sensing' G-protein coupled receptors (GPCRs) such as GPR43, which promotes immune homeostasis. The enormous amounts of SCFAs produced in the colon are sufficient to lower pH, which affects the function of proton sensors such as GPR65 expressed on the gut epithelium and immune cells. GPR65 is an anti-inflammatory Gαs-coupled receptor, which leads to the inhibition of inflammatory cytokines. The importance of GPR65 in inflammatory diseases is underscored by genetics associated with the missense variant I231L (rs3742704), which is associated with human inflammatory bowel disease, atopic dermatitis, and asthma. There is enormous scope to manipulate these pathways using specialized diets that release very high amounts of specific SCFAs in the gut, and we believe that therapies that rely on chemically modified foods is a promising approach. Such an approach includes high SCFA-producing diets, which we have shown to decrease numerous inflammatory western diseases in mouse models. These diets operate at many levels - increased gut integrity, changes to the gut microbiome, and promotion of immune homeostasis, which represents a new and highly promising way to prevent or treat human disease.

CEREBRAL HAEMODYNAMICS DURING FAILURE OF OXIDATIVE PHOSPHORYLATION FOLLOWING BIRTH ASPHYXIA

The Role of Short Chain Fatty Acids in Inflammation and Body Health

Short-chain fatty acids in diseases

Percentile Distributions of Birth Weight according to Gestational Ages in Korea (2010-2012)

The role of short-chain fatty acids in immunity, inflammation and metabolism

The health benefits of dietary short-chain fatty acids in metabolic diseases

Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease

Microbial Regulation of Host Physiology by Short-chain Fatty Acids

Gut microbiota derived short-chain fatty acids in physiology and pathology: An update

Regulation of short-chain fatty acids in the immune system

Dietary fiber and SCFAs in the regulation of mucosal immunity

Is there any effect of fetal gender on the markers of first trimester Down's syndrome screening?

Short‐chain fatty acids: bridges between diet, gut microbiota, and health

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis

Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections

The role of short chain fatty acids in appetite regulation and energy homeostasis

Regulation of immune cell function by short-chain fatty acids

[The role of short-chain fatty acids in inflammatory bowel diseases and colorectal cancer]

A major mechanism for immunomodulation: Dietary fibres and acid metabolites

Short-chain Fatty Acids and Cancer